OLUMIANT

Product Overview

About OLUMIANT

OLUMIANT is a medication that contains the active ingredient BARICITINIB, a Janus kinase (JAK) inhibitor. It is primarily used to treat certain inflammatory and autoimmune conditions, providing relief from symptoms and improving quality of life for patients. OLUMIANT works by targeting specific pathways in the body that contribute to inflammation and immune system dysregulation.

Key Benefits & Uses

• Treatment of moderate to severe rheumatoid arthritis in adults who have had an inadequate response to one or more disease-modifying antirheumatic drugs
• Treatment of active psoriatic arthritis in adults who have had an inadequate response to one or more disease-modifying antirheumatic drugs
• Treatment of moderate to severe atopic dermatitis in adults who are candidates for systemic therapy

Active Ingredient & Action

BARICITINIB, the active ingredient in OLUMIANT, selectively inhibits JAK1 and JAK2 enzymes, which play a crucial role in the signaling of various cytokines and growth factors involved in inflammation and immune response. By inhibiting these enzymes, BARICITINIB reduces inflammation and modulates the immune system, leading to an improvement in symptoms and disease activity.

Important Notes

Patients should take OLUMIANT as directed by their healthcare provider and follow all instructions carefully. It is essential to discuss the potential benefits and risks of OLUMIANT with a healthcare professional, including the risk of serious infections, malignancies, and other adverse effects. Regular monitoring and follow-up appointments are necessary to ensure safe and effective treatment.